Latest Breaking News On - Faces litigation from - Page 1 : comparemela.com

The gene therapy programs of Lexeo Therapeutics span rare forms of cardiomyopathy and certain types of Alzheimer’s disease. But Lexeo’s IPO comes as a rival gene therapy developer sues the biotech, claiming its work employs stolen trade secrets.

New yorkUnited statesCornell universityNolan townsendRocket pharmaceuticalsRocket pharmaceuticals incLexeo therapeuticsNew york based lexeoLexeo alzheimerYork based lexeoRonald crystalWeill cornell medicineFaces litigation fromGene therapySouthern districtNew jersey based